Munafa Stock Market Course + Intraday & FNO calls 
Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)
Technical Analysis Report for NASDAQ stock SMMT Summit Therapeutics. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics
Summit Therapeutics Opened at 16.00 and Closed at: 16.19, which is -2.47% of previous session's close. It moved within a range of 15.85 and 16.41
The session was a Bullish session with an average volume of 1867200, which is -28.59% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Golden cross was found 8 days back on short term averages
Support for tomorrow is 16.02 and resistance for tomorrow is 16.58
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 15.89, 15.59 resistance for tomorrow's hourly charts is 16.45, 16.71
10 Day SMA for Summit Therapeutics (SMMT) is 15.98 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Summit Therapeutics (SMMT) is 15.38 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Summit Therapeutics (SMMT) is 16.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 17.61 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Summit Therapeutics is 20.47 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Summit Therapeutics is at 15.38 and 200 DMA is at 20.47, while 50 DMA and 100 DMA are at 16.48 and 17.61 respectively
Summit Therapeutics (SMMT) moving average of 20 SMA is at 15.38 and 20 EMA is at 15.81
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 16.19 | 15.38 | 15.81 |
| 27 Fri Feb | 16.59 | 15.28 | 15.77 |
| 26 Thu Feb | 15.80 | 15.17 | 15.68 |
| 25 Wed Feb | 15.68 | 15.15 | 15.67 |
| 24 Tue Feb | 16.12 | 15.15 | 15.67 |
| 23 Mon Feb | 16.09 | 15.14 | 15.62 |
Summit Therapeutics (SMMT) moving average of 50 SMA is at 16.48 and 50 EMA is at 16.38
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 16.19 | 16.48 | 16.38 |
| 27 Fri Feb | 16.59 | 16.49 | 16.39 |
| 26 Thu Feb | 15.80 | 16.51 | 16.38 |
| 25 Wed Feb | 15.68 | 16.54 | 16.4 |
| 24 Tue Feb | 16.12 | 16.58 | 16.43 |
| 23 Mon Feb | 16.09 | 16.61 | 16.44 |
Summit Therapeutics (SMMT) moving average of 100 SMA is at 17.61 and 100 EMA is at 17.6
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 16.19 | 17.61 | 17.6 |
| 27 Fri Feb | 16.59 | 17.67 | 17.63 |
| 26 Thu Feb | 15.80 | 17.73 | 17.65 |
| 25 Wed Feb | 15.68 | 17.78 | 17.69 |
| 24 Tue Feb | 16.12 | 17.83 | 17.73 |
| 23 Mon Feb | 16.09 | 17.88 | 17.76 |
Summit Therapeutics (SMMT) moving average of 200 SMA is at 20.47 and 200 EMA is at 18.92
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 16.19 | 20.47 | 18.92 |
| 27 Fri Feb | 16.59 | 20.51 | 18.95 |
| 26 Thu Feb | 15.80 | 20.55 | 18.97 |
| 25 Wed Feb | 15.68 | 20.59 | 19 |
| 24 Tue Feb | 16.12 | 20.64 | 19.03 |
| 23 Mon Feb | 16.09 | 20.68 | 19.06 |
Summit Therapeutics has performed better than Xenon Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Trupanion Inc in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Tg Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Tenax Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Si Bone in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Ultragenyx Pharmaceutical in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Ptc Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than National Research in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Mesoblast in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Livanova Plc in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Agios Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Assembly Biosciences in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Assertio Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Aurinia Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Celldex Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 8.07% more returns!
Summit Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Denali Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Enanta Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics has performed better than Integra Lifesciences in short term. Holding Summit Therapeutics could be a better choice for now!
Summit Therapeutics Technical analysis of indicators
Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Summit Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Summit Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Summit Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Summit Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.02 and Summit Therapeutics SMMT stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.
Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SMMT Experts View which covers a lot of information including buying and selling signals
SMMT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
